In This Article:
MESQUITE, NV / ACCESSWIRE / January 10, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated medical cannabis telemedicine service - now offers its online medical cannabis card service to patients in the state of Arkansas.
"Our trusted telemedicine portal is ready to provide Arkansas medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor," said PrestoDoctor COO Rob Tankson.
Founded in 2015, PrestoDoctor has provided experienced and compassionate telemedicine care to more than 100,000 patients in thirteen states and is pleased to begin offering the same quality of service to patients in Arkansas.
"Arkansas should produce substantial appointments and increasing revenues for PrestoDoctor, and as medical cannabis continues to be available in more states, PrestoDoctor will be seeking to help those patients by safely connecting them to doctors from the comfort of their own home through PrestoDoctor's proprietary portal," stated Cannabis Sativa CEO David Tobias.
About PrestoDoctor
PrestoDoctor is rated the #1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, Illinois, Iowa, Texas, Louisiana, Ohio, and now Arkansas. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 21,000 5-star reviews.
About Cannabis Sativa, Inc.
Cannabis Sativa, Inc. ("CBDS") is engaged in telehealth, and the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes and operates subsidiary PrestoDoctor®.